Prolacta Bioscience is a biotechnology company that develops and manufactures human milk-based nutritional products for premature infants in neonatal intensive care units (NICUs). The company's products include human milk-based fortifiers, human milk-based caloric supplements, and donor milk. Prolacta Bioscience was founded in 1999 and is headquartered in City of Industry, California. The company's mission is to improve the health and outcomes of premature infants through the use of human milk-based nutritional products. Prolacta Bioscience has partnerships with over 200 hospitals in the United States and has donated over $7 million worth of human milk-based nutritional products to premature infants in need.